ELITE PHARMACEUTICALS INC /NV/ Quarterly Return On Equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Elite Pharmaceuticals Inc /Nv/ quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2024.
  • Elite Pharmaceuticals Inc /Nv/ Return On Equity for the quarter ending September 30, 2024 was -12.2 %, a 123% decline year-over-year.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2023 was 71.9 %, a 340% increase from 2022.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2022 was 16.3 %, a 72.8% decline from 2021.
  • Elite Pharmaceuticals Inc /Nv/ annual Return On Equity for 2021 was 60.1 %, a 56.2% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -12.2 -65.2 -123% Jul 1, 2024 Sep 30, 2024
Q2 2024 37.8 +22.7 +150% Apr 1, 2024 Jun 30, 2024
Q1 2024 44.9 +32.2 +252% Jan 1, 2024 Mar 31, 2024
Q4 2023 41.3 +14.6 +54.7% Oct 1, 2023 Dec 31, 2023
Q3 2023 53.1 +27.1 +105% Jul 1, 2023 Sep 30, 2023
Q2 2023 15.1 -13.9 -47.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 12.7 -28.1 -68.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 26.7 -3.93 -12.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 25.9 -5.82 -18.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 29 -9.74 -25.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 40.8 +6.42 +18.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 30.6 -17.8 -36.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 31.8 +8.92 +39.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 38.7 +59 Apr 1, 2021 Jun 30, 2021
Q1 2021 34.4 +94.9 Jan 1, 2021 Mar 31, 2021
Q4 2020 48.5 +1.46K Oct 1, 2020 Dec 31, 2020
Q3 2020 22.8 -306 -93.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -20.3 -1.04K -102% Apr 1, 2020 Jun 30, 2020
Q1 2020 -60.5 +1.72K +96.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -1.41K -1K -243% Oct 1, 2019 Dec 31, 2019
Q3 2019 329 +526 Jul 1, 2019 Sep 30, 2019
Q2 2019 1.02K +1.09K Apr 1, 2019 Jun 30, 2019
Q1 2019 -1.78K -1.71K -2387% Jan 1, 2019 Mar 31, 2019
Q4 2018 -412 -373 -964% Oct 1, 2018 Dec 31, 2018
Q3 2018 -197 -185 -1521% Jul 1, 2018 Sep 30, 2018
Q2 2018 -64.4 -67.2 -2379% Apr 1, 2018 Jun 30, 2018
Q1 2018 -71.6 -107 -303% Jan 1, 2018 Mar 31, 2018
Q4 2017 -38.7 +362 +90.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -12.1 -5.86 -93.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 2.82 -8.72 -75.5% Apr 1, 2017 Jun 30, 2017
Q1 2017 35.3 +33.3 +1693% Jan 1, 2017 Mar 31, 2017
Q4 2016 -400 -444 -1005% Oct 1, 2016 Dec 31, 2016
Q3 2016 -6.28 +8.62 +57.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 11.5 +45.8 Apr 1, 2016 Jun 30, 2016
Q1 2016 1.97 +12.2 Jan 1, 2016 Mar 31, 2016
Q4 2015 44.2 -75.4 -63% Oct 1, 2015 Dec 31, 2015
Q3 2015 -14.9 -163 -110% Jul 1, 2015 Sep 30, 2015
Q2 2015 -34.2 -260 -115% Apr 1, 2015 Jun 30, 2015
Q1 2015 -10.2 -403 -103% Jan 1, 2015 Mar 31, 2015
Q4 2014 120 -6.95 -5.49% Oct 1, 2014 Dec 31, 2014
Q3 2014 148 +175 Jul 1, 2014 Sep 30, 2014
Q2 2014 226 +331 Apr 1, 2014 Jun 30, 2014
Q1 2014 393 +402 Jan 1, 2014 Mar 31, 2014
Q4 2013 127 +87.3 +222% Oct 1, 2013 Dec 31, 2013
Q3 2013 -27 -68.4 -165% Jul 1, 2013 Sep 30, 2013
Q2 2013 -105 -78.1 -289% Apr 1, 2013 Jun 30, 2013
Q1 2013 -8.99 -74.6 -114% Jan 1, 2013 Mar 31, 2013
Q4 2012 39.3 -64.9 -62.3% Oct 1, 2012 Dec 31, 2012
Q3 2012 41.5 Jul 1, 2012 Sep 30, 2012
Q2 2012 -27 Apr 1, 2012 Jun 30, 2012
Q1 2012 65.6 Jan 1, 2012 Mar 31, 2012
Q4 2011 104 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.